Abstract
Objective We utilized epigenome-wide DNA methylation data to estimate/compare white blood cell (WBC) proportions in plasma across preeclamptic (case) and uncomplicated, normotensive (control) pregnancy.
Methods We previously collected methylation data using Infinium® MethylationEPIC Beadchips during the three trimesters in 28 cases and 28 controls (21 Black, 7 White participants/group). We employed Houseman’s regression calibration method to estimate and compare neutrophil, monocyte, B cell, NK cell, CD4+ T and CD8+ T cell proportions across pregnancy and between cases and controls.
Results We observed changes in WBC proportions across pregnancy within cases and controls that varied by cell type and race. Neutrophils represented the largest WBC mean proportion in all three trimesters for cases (Mean±SD: 67.2±9.6% – 74.4±12%) and controls (64.2±11% – 74.0±7.9%). Mean B cell proportions were significantly lower in cases than controls in Trimester 1 (5.25±0.02% versus 6.30±0.02%, p=0.02). The remaining mean cell proportions did not significantly differ in the overall sample. Stratified analyses revealed race-specific differences. In White participants (n=14): (1) neutrophil proportions were significantly higher in cases in Trimester 1 (p=0.04), but significantly lower in Trimester 2 (p=0.02), (2) B cell proportions were significantly lower in cases in Trimester 1 (p=0.001). No significant differences were detected among Black participants (n=42).
Conclusions Although chronic inflammation characterizes preeclampsia, few studies have investigated WBCs across pregnancy. We report differences between cases and controls across pregnancy. Our findings in a small sample demonstrate the need for additional studies investigating the relationship between race and WBCs in pregnancy, which could provide insight into preeclampsia pathophysiology.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by funding from the National Institutes of Health (R21HD092770, T32NR009759, P01HD30367).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study received ethics committee approval from the University of Pittsburgh Institutional Review Board, and participants provided written informed consent for participation in the parent and follow-up studies.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author Email Addresses: Mitali Ray, Postdoctoral Scholar: m.ray{at}pitt.edu
Lacey W. Heinsberg, Postdoctoral Scholar: law145{at}pitt.edu
Yvette P. Conley, Professor: yconley{at}pitt.edu
James M. Roberts, Professor: jroberts{at}mwri.magee.edu
Arun Jeyabalan, Associate Professor: jeyaax{at}mail.magee.edu
Carl A. Hubel, Associate Professor: chubel{at}mwri.magee.edu
Daniel E. Weeks, Professor: weeks{at}pitt.edu
Mandy J. Schmella, Assistant Professor: mjb111{at}pitt.edu
Data Availability
dbGAP, accession number: phs001937.v1.p1
https://www.ncbi.nlm.nih.gov/gap/advanced_search/?TERM=phs001937.v1.p1